Overview
Founded in 1978, CD&R is an investment firm with an investment strategy predicated on building stronger, more profitable businesses. The firm's full name is Clayton Dubilier & Rice, LLC, and it focuses exclusively on private equity. We work collaboratively with corporate and family business sellers on transactions to maximize value. We believe many corporations, CEOs and entrepreneurs select CD&R as their partner because of our reputation for trustworthiness and operational leadership.
We practice investing as a craft, relying on a dedicated and cohesive team with a shared sense of purpose and values. Our investment approach blends skilled investment judgment with extensive experience driving growth and operating excellence. The firm partners with management teams with the goal of building businesses that generate long-term value. It invests in sectors where it has industry operating expertise and works with its portfolio companies to develop and deploy value creation plans that support long-term growth.
CD&R describes its approach as defined by a commitment to trust, partnership, creativity and operational excellence. The firm states that its stewardship aims to drive sustainable growth and create economic opportunity for the people its businesses employ and the communities in which they operate. It also has a foundation, the CD&R Foundation.
Office locations
Similar companies
- Hellman & FriedmanFinancial Services · San Francisco, CA
- KKRFinancial Services · New York
- BlackstoneFinancial Services · New York, NY
- Thoma BravoFinancial Services · Chicago, Illinois
- CVCInvestment Management · Luxembourg
- TPGFinancial Services · San Francisco, California
- AdventInvestment Management · Boston, Massachusetts
- The Carlyle GroupFinancial Services · Washington, DC
- Warburg Pincus LLCFinancial Services · New York, NY
- Apollo Global Management, Inc.Financial Services · New York
Recent posts from the CD&R blog
- For more than 45 years, Option Care Health has helped transform the way infusion therapy is delivered…
bringing care to where patients are most comfortable: at home and in their communities. Today, CD&R and McKesson announced a definitive agreement to acquire the company.
- We are pleased to welcome Giovanni Caforio as an Operating Advisor to CD&R funds.
Currently Board Chair of Novartis, Giovanni has more than 35 years of leadership experience across the global biopharmaceutical industry, including serving as CEO and Chairman of Bristol Myers Squibb. He joins CD&R's team of Operating Advisors, bringing a deep understanding of innovation, commercialisation and global operations, combined with a patient-centred focus.